FOURTH LOAN MODIFICATION AGREEMENTFourth Loan Modification Agreement • May 9th, 2014 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
This Fourth Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of March 26, 2014, by and between SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”) and AEGERION PHARMACEUTICALS, INC., a Delaware corporation with its chief executive office located at 101 Main Street, Suite 1850, Cambridge, Massachusetts 02142 (“Borrower”).
